From the results of hormone receptor expression, although the expected therapeutic effects of hormone receptor-targeting endocrine drugs may not be significantly different from those of other breast cancer patients, endocrine drugs may also benefit estrogen receptor-positive CHBC patients. Here, ESR1 is linked to breast carcinoma.